NINFA PEREZ: Open Payments
NPI 1710994991 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 9 payments from 7 companies in 2025. Trend: 2023 $93 · 2024 $210 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $46 |
| Ardelyx, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: TARPEYO, IBSRELA, Kerendia, TAVNEOS, LOKELMA, JYNARQUE, JARDIANCE.
Industry payments across TX — which companies pay providers there.
